ChadDGalderisiDO

Pathology • Portland, OR

Molecular Genetics, Anatomic Pathology, Clinical Pathology

VP, Global Medical Director

Join to view full profile

Dr. Galderisi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Galderisi's full profile

Already have an account?

Office
1341 Sw Custer Dr
Portland, OR 97219
Phone+1 503-459-4974

Education & Training

Penn State Milton S Hershey Medical CenterResidency, Pathology-Anatomic and Clinical, 2001 - 2005
Philadelphia College of Osteopathic MedicineClass of 2001

Certifications & Licensure

NY State License 2024 - 2026
CA State License 2023 - 2025
MA State License 2012 - 2025
OR State License 2004 - 2025
WA State License 2010 - 2025
PA State License 2001 - 2005
American Board of Pathology Anatomic Pathology
American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

67 citations
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer
David L. Rimm, Samuel C Y Leung, Lisa M. McShane, Yalai Bai, Anita Bane
Modern Pathology. 2019-01-01
18 citations
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study.
Balazs Acs, Samuel C Y Leung, Kelley M Kidwell, Indu Arun, Renaldas Augulis
Modern Pathology. 2022-10-01
64 citations
Activity of the Fibroblast Growth Factor Receptor Inhibitors Dovitinib (TKI258) and NVP-BGJ398 in Human Endometrial Cancer Cells
Gottfried E. Konecny, Teodora Kolarova, Neil A. O'Brien, Boris Winterhoff, Guorong Yang
Molecular Cancer Therapeutics. 2013-05-01

Journal Articles

An International Multicenter Study to Evaluate Reproducibility of Automated Scoring for Assessment of Ki67 in Breast Cancer
Richard Levenson, David L Rimm, Daniel F Hayes, Chad Galderisi, Liron Pantanowitz, Nature

Lectures

Development and Validation of a Highly Sensitive e1a2 (p190) BCR-ABL Test to Determine Complete Molecular Response (Minimal Residual Disease Negative) As a Primary End...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018